Céline JAUDOINa, Isabelle GRILLOb, Fabrice COUSINc, Maria GEHRKEa, Malika OULDALId, Ana-Andreea ARTENId, Luc PICTONe, Christophe RIHOUEYe, Fanny SIMELIEREa, Amélie BOCHOTa, Florence AGNELYa

a Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 5 rue J-B Clément, 92296 Châtenay-Malabry, France.

b Institut Laue-Langevin, 71 avenue des Martyrs, 38042 Grenoble, France.

c Laboratoire Léon Brillouin, Université Paris-Saclay, UMR12 CEA-CNRS, 91191 Gif-sur-Yvette, France.

d Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198, Gif-sur-Yvette, France.

e Laboratoire Polymères, Biopolymères, Surfaces (PBS), UMR CNRS 6270, Normandie University, UNIROUEN, boulevard Maurice de Broglie, 76821 Mont-Saint-Aignan, France.

See the full published paper.

In drug delivery, nanocarriers provide numerous advantages over conventional forms. Indeed, they can sustain drug release, target specific organs, increase therapeutic index, and protect poorly stable molecules. Among the nanomedicines on the market, liposomes are predominant due to their excellent safety profile and versatility. They are made of lipid bilayers surrounding one or several aqueous compartments, enabling the encapsulation of both lipophilic and hydrophilic molecules. Besides, their size (50 nm to 5 microns) and surface are easily tunable.

These liposomes are often incorporated within hydrogels to design locally injectable drug delivery systems that enable targeting local therapies for some tissues that are hardly accessible from the bloodstream. A strategy for designing such hydrogels is to mix the liposomes with hyaluronic acid (HA). This linear polyanionic polymer is naturally present in the human body, highly biocompatible, and biodegradable. Due to their shear thinning behavior, concentrated solutions of HA are easily injectable through fine needles.

From a therapeutic point of view, mixtures of HA with liposomes have shown their efficacy in otology and ophthalmology. However, little is known about their microstructure. It prompted us to perform an exhaustive study on HA/liposome mixtures. We assessed the influence of liposome surface properties (neutral, cationic, anionic, or anionic and covered with poly(ethylene glycol)), HA concentration, and encapsulation within liposomes [1] of a small corticoid (dexamethasone phosphate)[1]. We combined Small Angle Neutron Scattering with several complementary methods (cryo-electron microscopy, dynamic light scattering, size exclusion chromatography, and rheology).

The first important finding is that liposomes keep their integrity in HA, whatever the conditions probed. Second, entropic effects and the interactions of HA chains with the liposomes’ surface drive the dispersion of liposomes within the HA network. Indeed, when there are repulsions or no electrostatic interaction between both objects, a depletion mechanism leads to the substantial aggregation of the liposomes. Anionic and PEGylated liposomes form dense clusters with an amorphous organization, whether the corticoid is or not encapsulated (Figure 1.a). The corticoid encapsulation does not modify this organization. Conversely, cationic liposomes form less dense aggregates and are better dispersed due to their electrostatic complexation with HA chains (figure 1.b).

Figure 1. Schematic representation of the microstructure of HA-liposome mixtures. From left to right: anionic liposomes, PEGylated liposomes, PEGylated liposomes containing encapsulated dexamethasone phosphate (corticoid), cationic liposomes.

[1] C. Jaudoin et al, J. Colloid. Int. Science, 2022, 628, 995–1007.